NORDIC PHARMACEUTICALS ApS — Credit Rating and Financial Key Figures

CVR number: 27430015
Hammerholmen 44, 2650 Hvidovre

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit1 268.58602.01652.99779.21551.90
Employee benefit expenses-1 144.74- 438.95- 492.26- 574.08- 400.87
EBIT123.84163.06160.73205.12151.03
Other financial expenses-90.58-88.80-69.17-97.47- 105.65
Pre-tax profit33.2674.2791.56107.6645.38
Income taxes-7.32-16.34-20.21-23.85-36.02
Net earnings25.9457.9371.3583.809.35

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Finished products/goods468.86362.73758.51746.48643.06
Inventories total468.86362.73758.51746.48643.06
Current trade debtors2 606.861 452.641 809.812 104.451 926.33
Current deferred tax assets41.6825.6825.6825.68
Short term receivables total2 648.531 478.321 835.492 130.131 926.33
Other current investments5.855.855.859.039.03
Cash and bank deposits2.58215.224.895.280.78
Cash and cash equivalents8.43221.0710.7414.319.81
Balance sheet total (assets)3 125.822 062.112 604.742 890.912 579.19

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital200.00200.00200.00200.00200.00
Retained earnings1 063.501 089.441 147.371 218.721 302.52
Profit of the financial year25.9457.9371.3583.809.35
Shareholders equity total1 289.441 347.371 418.721 502.521 511.88
Non-current liabilities total
Current loans from credit institutions773.50634.63802.71764.09
Current trade creditors215.66258.79325.57315.17203.58
Current owed to group member125.20110.2485.47143.67
Short-term deferred tax liabilities6.3416.2119.854.35
Other non-interest bearing current liabilities722.03339.38124.13106.9995.31
Current liabilities total1 836.38714.751 186.021 388.391 067.32
Balance sheet total (liabilities)3 125.822 062.112 604.742 890.912 579.19
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.